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a b s t r a c t 
Methylaspartate ammonia-lyase (MAL; EC 4.3.1.2) catalyzes the reversible addition of ammonia
to mesaconate to yield L - threo -(2 S ,3 S )-3-methylaspartate and L - erythro -(2 S ,3 R )-3-methylaspartate as
products. In the proposed minimal mechanism for MAL of Clostridium tetanomorphum , Lys-331 acts as
the ( S )-speciﬁc base catalyst and abstracts the 3 S- proton from L - threo- 3-methylaspartate, resulting in
an enolate anion intermediate. This enolic intermediate is stabilized by coordination to the essential
active site Mg 2 + ion and hydrogen bonding to the Gln-329 residue. Collapse of this intermediate re-
sults in the release of ammonia and the formation of mesaconate. His-194 likely acts as the ( R )-speciﬁc
base catalyst and abstracts the 3 R -proton from the L - erythro isomer of 3-methylaspartate, yielding the
enolic intermediate. In the present study, we have investigated the importance of the residues Gln-73,
Phe-170, Gln-172, Tyr-356, Thr-360, Cys-361 and Leu-384 for the catalytic activity of C. tetanomorphum
MAL. These residues, which are part of the enzyme surface lining the substrate binding pocket, were
subjected to site-directed mutagenesis and the mutant enzymes were characterized for their structural
integrity, ability to catalyze the amination of mesaconate, and regio- and diastereoselectivity. Based on
the observed properties of the mutant enzymes, combined with previous structural studies and protein
engineering work, we propose a detailed catalytic mechanism for the MAL-catalyzed reaction, in which
the side chains of Gln-73, Gln-172, Tyr-356, Thr-360, and Leu-384 provide favorable interactions with
the substrate, which are important for substrate binding and activation. This detailed knowledge of the
catalytic mechanism of MAL can serve as a guide for future protein engineering experiments. 
C © 2013 The Authors. Published by Elsevier B.V. on behalf of Federation of European Biochemical












Fig. 1. MAL catalyzed reversible amination of mesaconate ( 1 ) to yield l - threo -(2 S ,3 S )- 






 1. Introduction 
The enzyme methylaspartate ammonia-lyase (MAL; EC 4.3.1.2)
catalyzes the reversible addition of ammonia to mesaconate ( 1 ) to
yield l - threo -(2 S ,3 S )-3-methylaspartate ( 2 ) and l - erythro -(2 S ,3 R )-3-
methylaspartate ( 3 ) as products ( Fig. 1 ) [ 1 , 2 ]. MAL is used by the
bacterium Clostridium tetanomorphum H1 as part of a catabolic path-
way that converts l -glutamate, via 2 , to yield acetyl-CoA [ 1 –3 ]. In
recent years, MAL has gained a lot of interest because of its potential
for application in the asymmetric synthesis of a wide variety of aspar-
tic acid derivatives [ 4 –8 ]. These non-proteinogenic amino acids are
highly valuable as tools for biological research and as chiral building
blocks for pharma- and nutraceuticals [ 9 –14 ]. 
The structure of MAL from C. tetanomorphum (PDB: 1KCZ ) and
that of the isozyme from Citrobactor amalonaticus (PDB: 1KKR ) have 
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http://dx.doi.org/10.1016/j.fob.2013.07.002 been solved by X-ray crystallography [ 15 , 16 ]. On the basis of these
structural studies [ 15 –17 ], combined with kinetic isotope measure-
ments [ 18 , 19 ] and mutagenesis experiments [ 20 ], a minimal mech-
anism has emerged for the MAL-catalyzed reaction. In this proposed
mechanism, an ( S )-speciﬁc (Lys-331) or ( R )-speciﬁc (His-194) cat-
alytic base abstracts the C3 proton of the respective stereoisomer of
3-methylaspartate to generate an enolate anion intermediate that is
stabilized by a hydrogen bond interaction with Gln-329 and coor-
dination to the essential active site Mg 2 + ion [ 20 ]. Collapse of the
enolic intermediate results in the elimination of ammonia and yields
1 . This mechanism, however, is far from complete and the impor-
tance of other residues for the catalytic activity of MAL has not been
investigated yet. ean Biochemical Societies. Open access under CC BY-NC-ND license.




















































Fig. 2. Crystal structure of MAL in complex with the natural substrate l - threo -(2 S ,3 S )- 
3-methylaspartate (PDB: 1KKR ) [ 16 ]. (a) Close-up of the active site showing the 
hydrogen-bond interactions between the substrate’s carboxylate groups (C1 and C4) 
and the side chains of His-194, Gln-329, Gln-172 and Thr-360, or the main chain NH 
of Cys-361. The carbon atoms of the active site residues are shown in green, and those 
of the substrate in cyan. Hydrogen bonds are represented as dashed lines. The distance 
(in A˚) between the C3 atom of the substrate and side chain of Lys-331 is shown (atoms 
connected by a solid line). The magnesium ion is shown as a magenta sphere. (b) Close- 
up of the active site showing the hydrogen-bond interactions between the substrate’s 
amino group and the side chains of Gln-73 (via a water molecule) and Gln-172, as well 
as the observed distances (in A˚, atoms connected by solid lines) between the substrate’s 
methyl group and the side chains of Leu-384, Phe-170 and Tyr-356. The magnesium 
ion and water molecule are shown as magenta and yellow spheres, respectively. Colour 
scheme as in (a). The ﬁgures were prepared with Pymol ( http: // www.pymol.org ) [ 30 ]. 
(For interpretation of the references to colour in this ﬁgure legend, the reader is referred 
to the web version of this article.) The crystal structure of MAL complexed with its natural substrate 
 shows that the surface of the enzyme lining the substrate bind- 
ng pocket is provided, in part, by residues Gln-73, Phe-170, Gln-172, 
yr-356, Thr-360, Cys-361 and Leu-384 ( Fig. 2 ) [ 16 ]. These residues 
re highly conserved in known MALs [ 16 ], but not in other members 
f the enolase superfamily [ 15 ]. In the present study, we performed 
ite-directed mutagenesis experiments on all these residues to pro- 
ide insight into their roles in the catalytic mechanism for the MAL- 
atalyzed reaction. The mutant enzymes were characterized for their 
tructural integrity, ability to catalyze the amination of mesaconate, 
nd regio- and diastereoselectivity. Based on the observed properties 
f the mutant enzymes, combined with previous structural studies 
nd recent enzyme engineering work, we present a detailed catalytic 
echanism for the MAL-catalyzed reaction, with important roles for 
ln-73, Gln-172, Tyr-356, Thr-360, and Leu-384 in substrate binding 
nd activation. 
. Materials and methods 
.1. Materials 
Mesaconic acid and other chemicals were purchased from Sigma–
ldrich Chemical Co. (St Louis, MO, USA), unless stated otherwise. The 
ources for the media components, buffers, solvents, pre-packed PD- 
0 Sephadex G-25 columns, and molecular biology reagents, includ- 
ng PCR puriﬁcation, gel extraction, and Miniprep kits, are reported 
lsewhere [ 20 –22 ]. Oligonucleotides for DNA ampliﬁcation were syn- 
hesized by Operon Biotechnologies (Cologne, Germany). 
.2. Bacterial strains, plasmids and growth conditions 
Escherichia coli strain XL1-Blue (Stratagene, La Jolla, CA) was used 
or cloning and isolation of plasmids. E. coli strain TOP10 (Invitrogen) 
as used in combination with the pBAD / Myc -His A vector (Invitro- 
en) for recombinant protein production. E. coli cells were grown in 
uria–Bertani (LB) medium. When required, Difco agar (15 g / L), ampi- 
illin (Ap, 100 μg / mL), and / or arabinose (0.004% w / v) were added to 
he medium. 
.3. General methods 
Techniques for restriction enzyme digestions, ligation, transfor- 
ation, and other standard molecular biology manipulations were 
ased on methods described elsewhere [ 23 ] or as suggested by the 
anufacturer. PCR was carried out in a DNA thermal cycler (model 
S-1) obtained from Biolegio (Nijmegen, The Netherlands). DNA se- 
uencing was performed by Macrogen (Seoul, South Korea). Protein 
as analyzed by polyacrylamide gel electrophoresis (PAGE) under 
ither denaturing conditions using sodium dodecyl sulfate (SDS) or 
ative conditions on gels containing polyacrylamide (10%). The gels 
ere stained with Coomassie brilliant blue. Protein concentrations 
ere determined by the Waddell method [ 24 ]. Kinetic data were 
btained on a V-650 spectrophotometer from Jasco (IJsselstein, The 
etherlands). The kinetic data were ﬁtted by nonlinear regression 
ata analysis by using the Graﬁt program (Erithacus, Software Ltd., 
orley, UK) obtained from Sigma Chemical Co. The CD spectra were 
ecorded on a model 62A-DS spectropolarimeter from AVIV Biomed- 
cal Inc. (Lakewood, NJ, USA). 1 H NMR spectra were recorded on a 
arian Inova 500 (500 MHz) spectrometer using a pulse sequence for 
elective presaturation of the water signal. Chemical shifts for pro- 
ons are reported in parts per million scale ( δ scale) downﬁeld from 
etramethylsilane and are referenced to protium (H 2 O: δ = 4.80). 2.4. Construction, expression and puriﬁcation of MAL mutants 
The MAL mutants were generated by the overlap extension PCR 
method [ 25 ] using plasmid pBAD(MAL-His), which contains the wild- 
type MAL gene under the transcriptional control of the araBAD pro- 
moter [ 20 ], as the template. The ﬁnal PCR products were gel-puriﬁed, 
digested with Nde I and Hin dIII restriction enzymes, and ligated in 
frame with both the initiation ATG start codon and the sequence that 
codes for the polyhistidine region of the expression vector pBAD N / 
Myc -His A. All mutant genes were completely sequenced (with over- 
lapping reads) to verify that only the intended mutation had been 
introduced. Wild-type MAL and the mutant enzymes were overpro- 
duced in E. coli TOP10 cells and puriﬁed to near homogeneity by 
following a previously described protocol [ 20 ]. 














































Apparent kinetic parameters for the amination of mesaconate ( 1 ) catalyzed by wild- 
type or mutant MAL. a 
Enzyme k cat (s 
−1 ) K m for 1 (mM) k cat / K m (M −1 s −1 ) 
MAL b 61 ± 1 0.7 ± 0.02 8.7 × 10 4 
T360A 0.6 ± 0.1 15 ± 2.5 40 
T360S 35 ± 1 1.4 ± 0.3 2.5 × 10 4 
C361A 27.5 ± 2.5 2.9 ± 0.5 9.5 × 10 3 
C361K ND ND < 0.1 
Q172A > 20 > 60 3.4 × 10 2 
Q172N ND ND < 0.1 
Q73A 0.7 ± 0.1 0.2 ± 0.02 3.5 × 10 3 
Q73N ND ND < 0.1 
F170A 10 ± 1 0.9 ± 0.1 1.1 × 10 4 
Y356A > 0.7 > 60 12 
L384A > 16 > 60 2.7 × 10 2 
a The steady state kinetic parameters were determined in 500 mM Tris–HCl buffer 
(pH 9.0) containing 20 mM MgCl 2 and 400 mM NH 4 Cl at 30 
o C. Errors are standard 
deviations from each ﬁt. ND, not determined. 









































 2.5. Circular dichroism spectroscopy 
Circular dichroism (CD) spectra of the puriﬁed wild-type MAL and
the puriﬁed mutants were measured in Tris–HCl buffer (5 mM, pH
8.0), containing MgCl 2 (2 mM) and KCl (0.1 mM), at a concentration
of approximately 3.0 μM in a CD cell with an optical path length of
1.0 mm. 
2.6. Kinetic assay 
The amination of 1 catalyzed by wild-type or mutant MAL was
monitored by following the depletion of 1 at 240 nm or 270 nm
in 500 mM Tris–HCl buffer (pH 9.0), containing 20 mM MgCl 2 and
400 mM NH 4 Cl, at 30 
◦C as described previously [ 20 ]. The concentra-
tion of 1 used in the assay varied in the range 0.1–60 mM. 
2.7. Product analysis by 1 H NMR spectroscopy 
The amino acid products of the amination of 1 catalyzed by wild-
type or mutant MAL were identiﬁed by 1 H NMR spectroscopy. Reac-
tion mixtures consisted of 500 μL of a 1 M stock solution of NH 4 Cl in
water (pH 9.0, containing 20 mM MgCl 2 ), 100 μL of a 500 mM stock
solution of 1 in water (pH 9.0, containing 20 mM MgCl 2 ), and 100 μL
of D 2 O. Reactions were started by the addition of 200 μg of freshly
puriﬁed enzyme, and the reaction mixtures were incubated at 25 ◦C.
1 H NMR spectra were recorded 2 h and 7 days after the addition of
enzyme. Given that MAL catalyzes the fast anti -addition and much
slower syn -addition of ammonia to 1 [ 20 , 26 , 27 ], leading to threo -
(2 S ,3 S )-3-methylaspartate ( 2 ) and erythro -(2 S ,3 R )-3-methylaspartate
( 3 ), respectively, we allowed the amination reactions to run for 7 days
to detect the formation of low amounts of erythro product isomer, if
present. Product amounts were estimated by integration of the sig-
nals corresponding to 2 and 3 (if present). The 1 H NMR signals for 1 ,
2 and 3 have been reported previously [ 20 ]. 
3. Results 
3.1. Production, puriﬁcation and characterization of the MAL mutants 
The surface of the protein lining the substrate binding site is pro-
vided by the residues shown in Fig. 2 [ 16 ]. In a previous study, the
roles of residues His-194, Gln-329 and Lys-331 in the catalytic mech-
anism of the MAL-catalyzed reaction have been investigated by site-
directed mutagenesis [ 20 ]. The residues selected for mutagenesis in
the present study were Gln-73, Phe-170, Gln-172, Tyr-356, Thr-360,
Cys-361 and Leu-384 ( Fig. 2 ). Similar to wild-type MAL, all mutant
proteins were constructed as His 6 -tagged fusion proteins, produced
in E. coli TOP10 cells, and puriﬁed to > 95% homogeneity (as assessed
by SDS-PAGE) using a one-step Ni-based immobilized metal afﬁn-
ity chromatography procedure [ 20 ]. This yielded about 20–30 mg of
homogenous protein per liter of cell culture. 
Each MAL mutant was analyzed by non-denaturing PAGE (data
not shown). The mutant enzymes were found to migrate comparably
with the wild-type enzyme, which suggests that the homodimeric
association of the mutants was still intact. The structural integrity
of each mutant was also assessed by circular dichroism (CD) spec-
troscopy. The CD spectra of the mutants were comparable to that of
wild-type MAL, suggesting that the mutations did not result in any
major conformational changes (data not shown). 
3.2. Residues that interact with the substrate’s 1-carboxylate group 
The crystal structure of MAL in complex with 2 shows that the 1-
carboxylate group of the substrate has hydrogen-bonding interactions
with the main chain NH of Cys-361, the oxygen atom (O γ) of Thr-360,and the nitrogen atom (N 2) of Gln-172 ( Fig. 2 a) [ 16 ]. Residue Gln-
172 also interacts, via hydrogen-bonding, with the 2-amino group of
the substrate ( Fig. 2 b) [ 16 ]. To investigate the importance of these
residues for the catalytic activity and regio- and diastereoselectivity
of MAL, six single site-directed mutants were constructed in which
Thr-360 was replaced with either an alanine or a serine (T360A and
T360S), Cys361 with either an alanine or a lysine (C361A and C361K),
and Gln-172 with either an alanine or an asparagine (Q172A and
Q172N). The amination activities of the mutants were assayed using
1 as the substrate. 
The mutation of Thr-360 to an alanine has a large effect on the cat-
alytic efﬁciency of MAL. For the T360A mutant, a ∼100-fold decrease
in k cat and a ∼22-fold increase in K m was observed, which results in
a ∼2200-fold decrease in k cat / K m ( Table 1 ). Hence, the major effect of
this mutation is on the value of k cat . The mutation of Thr-360 to an-
other residue with an aliphatic hydroxyl group (serine), however, has
a less drastic effect on the catalytic efﬁciency. For the T360S mutant,
the k cat / K m is reduced only approximately 3.5-fold ( Table 1 ). 
Obviously, mutations at position 361 can not eliminate the main
chain NH interaction with the substrate. As might therefore be ex-
pected, the removal of the side chain at this position, by the substitu-
tion of Cys-361 with an alanine, has hardly any effect on the catalytic
efﬁciency of MAL. For the C361A mutant, there is a ∼2.2-fold decrease
in k cat and an approximately 4.2-fold increase in K m . As a result, the
k cat / K m is reduced only ∼9-fold ( Table 1 ). However, the introduc-
tion of a new side chain at position 361, by mutation of Cys-361 to a
lysine, essentially abolished enzymatic activity ( Table 1 ). Under the
conditions of the kinetic assay, no activity could be detected for this
mutant. 
The mutation of Gln-172 to an alanine (i.e., removal of the func-
tional side chain) has a large effect on the values of K m and k cat / K m .
For the Q172A mutant, a plot of various concentrations of 1 versus
the initial rates measured at each concentration remained linear up
to 60 mM. Hence, the Q172A mutant could not be saturated. Accord-
ingly, only the k cat / K m was determined, and this parameter is reduced
∼255-fold compared to that of wild-type MAL ( Table 1 ). Because the
increase in K m for the Q172A mutant is > 85-fold, the k cat must be > 20
s −1 . Surprisingly, the mutation of Gln-172 to an asparagine, which has
a side chain with a similar functional group, essentially abolished en-
zymatic activity ( Table 1 ). 
The amination of 1 catalyzed by wild-type MAL and the mutants
was also monitored by 1 H NMR spectroscopy to identify the products
of the reaction. This spectroscopic analysis showed that the ammonia
additions to 1 catalyzed by the MAL mutants lead to the same amino
acid product (i.e., 3-methylaspartate) as the corresponding wild-type
288 Hans Raj, G.J. Poelarends / FEBS Open Bio 3 (2013) 285–290 
Table 2 
Conversions and diastereomeric product ratios for the ammonia additions to 
mesaconate catalyzed by wild-type and mutant MAL. a 
Enzyme Con. (%) 2 h 
d.r. 
( threo:erythro ) b 
after 2 h Con. (%) 7 d 
d.r. 
( threo:erythro ) b 
after 7 d 
MAL 73 89:11 81 51:49 
T360A 38 93:7 82 54:46 
T360S 76 86:14 85 51:49 
C361A 47 > 95:5 78 53:47 
C361K 10 > 95:5 70 > 95:5 
Q172A 16 > 95:5 74 89:11 
Q172N 6 > 95:5 68 > 95:5 
Q73A 37 91:9 71 69:31 
Q73N 18 > 95:5 74 > 95:5 
F170A 63 > 95:5 83 55:45 
Y356A 24 > 95:5 74 80:20 
L384A 61 > 95:5 75 86:14 
a Reactions were monitored by 1 H NMR spectroscopy. 
b The d.r. [deﬁned as threo - 3 -methylaspartate ( 2 ): erythro - 3 -methylaspartate ( 3 )] of the 
amino acid product was determined by comparison of its 1 H NMR signals in the crude 








































 AL-catalyzed reaction. This demonstrates that the mutations at po- 
itions 172, 360 and 361 do not affect the regioselectivity of MAL. 
owever, varying diastereomeric product ratios were observed. Con- 
istent with the fact that MAL catalyzes the fast anti -addition and 
he much slower syn -addition of ammonia to 1 [ 20 ], leading to the 
hreo and erythro isomers of 3-methylaspartate, respectively, the 1 H 
MR spectra recorded after 2 h predominantly showed the forma- 
ion of 2 , whereas the signals corresponding to 3 mainly appeared in 
ater spectra ( Table 2 ). After 7 days of incubation, the Q172A, T360A, 
360S, and C361A mutant-catalyzed amination reactions resulted in 
4%, 82%, 85%, and 78% conversion of 1 into the amino acid product 
ith a diastereomeric ratio (d.r.) of 89:11, 54:46, 51:49, and 53:47, re- 
pectively ( Table 2 ). The reactions catalyzed by the Q172N and C361K 
utants, which have low-level amination activities, resulted in ∼70% 
onversion of 1 into 3-methylaspartate with a d.r. of > 95:5 ( Table 2 ). 
.3. Residues that interact with the substrate’s 2-amino group 
The crystal structure of MAL in complex with 2 shows that the 
-amino group of the substrate has hydrogen-bonding interactions 
ith the oxygen atom (O 1) of Gln-172 and, via a water molecule, 
ith the nitrogen atom (N 2) of Gln-73 ( Fig. 2 b) [ 16 ]. The importance
f Gln-172 for the catalytic activity of MAL is described above. To 
nvestigate the importance of the Gln-73 residue for the catalytic 
ctivity and regio- and diastereoselectivity of MAL, this residue was 
utated to either an alanine or an asparagine. These mutations are 
xpected to completely remove the functional side chain (Q73A) or to 
eplace the side chain with another one that has a similar functional 
roup (Q73N). The replacement of Gln-73 with an alanine resulted 
n an active enzyme with a 87-fold reduction in k cat and a 3.5-fold 
ecrease in K m , resulting in a ∼25-fold lower k cat / K m compared to 
ild-type MAL ( Table 1 ). Hence, the major effect of this mutation 
s on the value of k cat . Surprisingly, the Q73N mutant showed very 
ow-level amination activity, preventing the measurement of kinetic 
arameters ( Table 1 ). 
The ammonia additions to 1 catalyzed by the Q73A and Q73N mu- 
ants were also monitored by 1 H NMR spectroscopy to identify the 
mino acid products of these reactions. After a 7 days incubation pe- 
iod, the Q73A- and Q73N-catalyzed amination reactions resulted in 
1% and 74% conversion of 1 into 3-methylaspartate with d.r. values 
f 69:31 and > 95:5, respectively ( Table 2 ). No other amino acid prod- 
cts were observed, indicating that the regioselectivity of the enzyme 
s not inﬂuenced by the mutations at position 73. 3.4. Residues lining the binding site for the substrate’s 3-methyl group 
The crystal structure of MAL in complex with 2 suggests that the 
side chains of Phe-170, Tyr-356 and Leu-384 are involved in the for- 
mation of the binding pocket for the 3-methyl group of the substrate 
( Fig. 2 b) [ 16 ]. To study the importance of these residues for the cat- 
alytic activity and regio- and diastereoselectivity of MAL, each residue 
was replaced with an alanine. The mutation of Phe-170 to an alanine 
resulted in a mutant enzyme with a ∼6-fold decrease in k cat and a 
∼1.3-fold higher K m , which results in an approximately 8-fold de- 
crease in k cat / K m ( Table 1 ). The substitutions of Tyr-356 and Leu-384 
to an alanine, however, have a larger effect on the catalytic efﬁciencies 
of MAL ( Table 1 ). For both the Y356A and L384A mutants, saturation 
by substrate 1 (up to 60 mM) could not be achieved and therefore 
only the k cat / K m was determined. A 7250- and 320-fold reduction in 
k cat / K m was observed for the Y356A and L384A mutants, respectively. 
Hence, it is clear that the mutations at positions Tyr-356 and Leu-384 
largely inﬂuence the K m for 1 ( Table 1 ). 
The amination reactions catalyzed by the F170A, Y356A and L384A 
mutants were also followed by 1 H NMR spectroscopy. After an incu- 
bation period of 7 days, the F170A-, Y356A- and L384A-catalyzed 
reactions resulted in about 83%, 74% and 75% conversion of 1 into 
3-methylaspartate with d.r. values of 55:45, 80:20 and 86:14, respec- 
tively ( Table 2 ). No other amino acid products were observed, which 
indicates that the regioselectivity of the enzyme is also not inﬂuenced 
by the mutations at positions 170, 356 and 384. 
4. Discussion 
On the basis of previous kinetic isotope measurements [ 18 , 19 ], 
structural studies [ 15 , 16 ], and mutagenesis experiments [ 20 ], a min- 
imal mechanism has emerged for the MAL-catalyzed reaction. In this 
proposed mechanism, Lys-331 acts as the ( S )-speciﬁc base catalyst 
and abstracts the 3 S- proton from l - threo- 3-methylaspartate ( 2 ), re- 
sulting in an enolate anion intermediate ( 4 in Fig. 3 ). This enolic inter- 
mediate is stabilized by coordination to the essential active site Mg 2 + 
ion [ 28 ]. Residues His-194 and Gln-329 are thought to assist the Mg 2 + 
ion in binding the substrate’s 4-carboxylate group and stabilizing the 
enolate intermediate. Collapse of this intermediate results in the re- 
lease of ammonia and the formation of mesaconate ( 1 ). In addition to 
its proposed role in binding the 4-carboxylate group of the substrate, 
His-194 is believed to also act as the ( R )-speciﬁc base catalyst and ab- 
stracts the 3 R -proton from the l - erythro isomer of 3-methylaspartate, 
yielding the enolic intermediate 4 . The strongest support for this cat- 
alytic role of His-194 comes from the observation that the H194A 
mutant of MAL is highly diastereoselective and can be used as bio- 
catalyst in the synthesis of exclusively the threo isomers of various 
3-substituted aspartic acids [ 20 , 29 ]. In the present study, guided by 
the crystal structure of MAL complexed with the natural substrate 
2 , we have selected seven other active site residues for site-directed 
mutagenesis to provide further insight into the catalytic mechanism 
of MAL. The obtained results allow us to present a full catalytic mech- 
anism for the MAL-catalyzed reaction, detailed knowledge of which 
can serve as an important guide for future protein engineering exper- 
iments. 
The crystal structure of MAL in complex with 2 shows that the 
1-carboxylate group of the substrate has hydrogen-bond interactions 
with the main chain NH of Cys-361, O γ of Thr-360, and N 2 of Gln- 
172 ( Fig. 2 a) [ 16 ]. To examine the role of Gln-172 and Thr-360 in the
mechanism of the MAL-catalyzed reaction, we have mutated these 
two residues. Complete removal of the functionality at position Thr- 
360 by replacement with an alanine leads to a ∼2200-fold decrease in 
k cat / K m with a ∼22-fold increase in the K m for 1 . The same substitu- 
tion at position Gln-172 also results in a reduced catalytic efﬁciency 
with a large increase ( > 85-fold) in the K m for 1 . These observations, 
combined with the increase in activity and decrease in K m observed 
Hans Raj, G.J. Poelarends / FEBS Open Bio 3 (2013) 285–290 289 












































































































 with a serine mutation at position Thr-360, support a role for the
side chains of Thr-360 and Gln-172 in assisting the main chain NH
of Cys-361 to bind and position the substrate ( 1 , 2 or 3 ) through
hydrogen-bond interactions with its 1-carboxylate group. 
The crystal structure of MAL in complex with 2 shows that the
2-amino group of the substrate has hydrogen-bond interactions with
O 1 of Gln-172 and, via a water molecule, with N 2 of Gln-73 ( Fig. 2 b)
[ 16 ]. This suggests roles for the functional groups of these residues
in binding the amino group of 2 (or 3 ) in the deamination reaction
or ammonia in the reverse addition to 1 . Examination of the kinetic
properties of the amination reaction catalyzed by the Q73A mutant,
which is the only mutation at this position that resulted in an enzyme
with signiﬁcant activity, shows that there is only a minor effect on
the value of K m for 1 ( Table 1 ), suggesting that Gln-73 indeed does
not play a role in binding this substrate. One potential explanation for
the loss in activity (i.e., reduced k cat value) of the Q73A mutant is that
Gln-73 could bind and position ammonia in a favorable orientation
for amination of 1 . Support for this view is provided by a recent study
in which engineering of the amine binding pocket (i.e., saturation
mutagenesis at positions Gln-73 and Gln-172), followed by screen-
ing of mutants for enhanced activity towards methylamine addition
to 1 , also yielded mutant Q73A [ 21 ]. Interestingly, the Q73A muta-
tion moved the speciﬁcity of MAL away from ammonia and towards
alkylamines. For example, a comparison of k cat / K m values shows that
wild-type MAL is ∼500-fold more efﬁcient in ammonia addition to 1
than the Q73A mutant, whereas the Q73A mutant is at least 140-fold
more efﬁcient in the addition of methylamine to 1 . These observations
clearly indicate that Gln-73 is one of the residues that inﬂuences the
amine speciﬁcity of MAL, strongly supporting the proposed role for
Gln-73 in binding the amino group of 2 (or 3 ) in the deamination
reaction or ammonia in the reverse addition to 1 . 
The crystal structure of MAL complexed with 2 suggests that the
enzyme surface lining the binding site for the 3-methyl group of the
substrate is composed almost entirely of side chains, including those
of Phe-170, Tyr-356 and Leu-384 ( Fig. 2 b) [ 16 ]. To assess their role in
catalysis, we have mutated these residues to an alanine. Examination
of the kinetic properties for the Y356A and L384A mutants shows that
there is a signiﬁcant reduction in catalytic efﬁciency and a large in-
crease ( > 85-fold) in the K m for 1 , suggesting that these residues play
a major role in binding the methyl group of the substrate. By contrast
to these observations, examination of the kinetic properties for the
F170A mutant shows that there is only a small effect of replacing
Phe-170 to an alanine on the values of K m and k cat / K m , suggesting
that Phe-170 is not directly involved in binding the methyl group of
the substrate. Consistent with the observed distances between the
substrate’s methyl group and the side chains of Leu-384, Phe-170 and
Tyr-356 ( Fig. 2 b) [ 16 ], our results suggest that additional stabiliza-
tion of the substrate in the active site is provided by favorable van der
Waals packing interactions between the substrate’s methyl group andthe side chains of Tyr-356 and Leu-384, while the side chain of Phe-
170 is likely too far away to provide a stabilizing interaction. Strong
support for the interaction between Leu-384 and the methyl group
of the substrate also comes from a recent protein engineering study,
in which position Leu-384 was randomized, followed by screening of
mutants for amination activity towards 2-hexylfumarate [ 21 ]. This
approach yielded mutants L384G and L384A, and both mutations
moved the speciﬁcity of MAL away from mesaconate and towards the
unnatural substrate 2-hexylfumarate. Intriguingly, the L384A mutant
was shown to exhibit a broad substrate scope, including fumarate
derivatives with alkyl, aryl, alkoxy, aryloxy, alkylthio and arylthio
substituents at the C2 position. These observations indicate that Leu-
384 is one of the residues that inﬂuences the substrate (i.e., fumarate)
speciﬁcity of MAL, supporting a role for Leu-384 in assisting Tyr-356
to bind and position the substrate through van der Waals interactions
with its methyl group. 
Notably, all mutants described in this study retained the high re-
gioselectivity of the wild-type enzyme, producing 3-methylaspartate
as single amino acid product in the amination reaction. Hence, al-
tering the regioselectivity of MAL probably requires the synergistic
effects encountered by multiple simultaneous mutations. However,
although all mutants exclusively produce 3-methylaspartate, varying
diastereomeric ratios (i.e., mixtures of l - threo and l - erythro isomers of
3-methylasparate) were observed. Whereas the amination reactions
catalyzed by most mutants provided a mixture of threo and erythro
isomers, the amination reactions catalyzed by the C361K, Q172N, and
Q73N mutants provided a single diastereoisomer having the threo
conﬁguration ( Table 2 ). It is important to emphasize that the latter
mutants have very low-level amination activities. Given that for wild-
type MAL the rate of anti -addition is approximately 100-fold higher
than the rate for syn -addition [ 20 , 22 , 26 , 27 ], and assuming that for
these mutants both rates are equally reduced by the mutation, the
amount of syn -addition product (i.e., the erythro isomer) formed in
the reaction mixture might be too low to detect by 1 H NMR spec-
troscopy. Hence, these mutant enzymes do not necessarily have al-
tered diastereoselectivities. 
On the basis of the results described in this study, the previously
proposed minimal mechanism for the MAL-catalyzed deamination re-
action can now be extended ( Fig. 3 ). As described above, residues Lys-
331, His-194 and Gln-329 and the Mg 2 + ion play important roles in
formation and stabilization of the enolate anion intermediate 4 . In the
next step, this enolic intermediate collapses and eliminates ammonia
to form the mesaconate ( 1 ) product. Residues Gln-73 (via a water
molecule) and Gln-172 could position and ‘lock ’ the amino group in a
favorable orientation for deamination, whereas Thr-360 and Cys-361,
assisted by Gln-172, play important roles in binding the substrate’s
1-carboxylate group. In addition, residues Tyr-356 and Leu-384 pro-
vide stabilizing interactions with the substrate’s 3-methyl group. To-
gether, these interactions are important for the optimal positioning
and activation of the substrate, and are important determinants of the
substrate speciﬁcity of MAL. This detailed understanding of the cat-
alytic mechanism of MAL can serve as an important guide for future
engineering experiments that aim to further expand the substrate
scope of this fascinating enzyme. 
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